Stan, A D
Ghose, S
Zhao, C
Hulsey, K
Mihalakos, P
Yanagi, M
Morris, S U
Bartko, J J
Choi, C
Tamminga, C A
Article History
Received: 30 August 2013
Revised: 22 April 2014
Accepted: 24 April 2014
First Online: 10 June 2014
Competing interests
: Dr Tamminga is or has been a deputy editor for the American Psychiatric Association; an <i>ad hoc</i> consultant for Astellas, Eli Lilly and Lundbeck; a council member for the Brain & Behavior Research Foundation, the Institute of Medicine, the National Alliance on Mental Illness and the National Institute of Mental Health; an organizer for the International Congress on Schizophrenia Research; a consultant for Kaye Scholer; and a member of the advisory board of drug development for Intra-Cellular Therapies. The other authors declare no conflict of interest.